Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shimazui

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Urologia Internationalis|January 1, 1991
Evaluation of the invasive potential of superficial bladder cancer by adenosine triphosphate measurementK Koiso, R Nemoto, M Ohtani, et al.
Cancer Research|September 15, 1996
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumorsT Shimazui, J A Schalken, L A Giroldi, et al.
Japanese Journal of Clinical Oncology|January 23, 1998
A case of intravascular papillary endothelial hyperplasia (Masson's tumor) arising from renal sinusA Johraku, N Miyanaga, N Sekido, et al.
International Journal of Cancer|November 14, 1997
Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinomaT Shimazui, P P Bringuier, H van Berkel, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2000
A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective studyN Miyanaga, H Akaza, T Okumura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinomaT Shimazui, E Oosterwijk, H Akaza, et al.
Oncogene|October 22, 2008
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signalingT Kojima, T Shimazui, S Hinotsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group]K Uchida, H Akaza, T Shimazui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 29, 1998
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group]K Uchida, H Takeshima, K Kikuchi, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Urologia Internationalis|January 1, 1991
Evaluation of the invasive potential of superficial bladder cancer by adenosine triphosphate measurementK Koiso, R Nemoto, M Ohtani, et al.
Cancer Research|September 15, 1996
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumorsT Shimazui, J A Schalken, L A Giroldi, et al.
Japanese Journal of Clinical Oncology|January 23, 1998
A case of intravascular papillary endothelial hyperplasia (Masson's tumor) arising from renal sinusA Johraku, N Miyanaga, N Sekido, et al.
International Journal of Cancer|November 14, 1997
Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinomaT Shimazui, P P Bringuier, H van Berkel, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2000
A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective studyN Miyanaga, H Akaza, T Okumura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinomaT Shimazui, E Oosterwijk, H Akaza, et al.
Oncogene|October 22, 2008
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signalingT Kojima, T Shimazui, S Hinotsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group]K Uchida, H Akaza, T Shimazui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 29, 1998
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group]K Uchida, H Takeshima, K Kikuchi, et al.
Pageof 5